Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Leukemia Remission Confers a Leukemia-Free Survival Advantage
Corinne Summers(Seattle Children's Hospital), Rebecca Gardner(Seattle Children's Hospital), Julie R. Park(Seattle Children's Hospital), Qian Wu(Cancer Research Center), Adam Brand, Ann Dahlberg(Seattle Children's Hospital), Wenjun Huang(Lishui Central Hospital), Jenna Voutsinas(Fred Hutch Cancer Center), Wendy M. Leisenring(The University of Texas MD Anderson Cancer Center), Prabha Narayanaswamy, Michael C. Jensen(Seattle Children's Hospital), Colleen Annesley(Unknown), Marie Bleakley(Unknown)
Cited by 64
Related Papers
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k